E. D. Smurnyi

Lomonosov Moscow State University, Moskva, Moscow, Russia

Are you E. D. Smurnyi?

Claim your profile

Publications (2)0.94 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: General principles of the construction of expert systems for the elucidation of the structure of molecules from their spectra were considered. The principal attention was focused on systems based on the use of 2-D NMR spectra. The structural information extracted from 2D NMR spectra was characterized, and the strategy was outlined for structure elucidation under the conditions when the analyzed spectrostructural information is incomplete, fuzzy, and contradictory. The most advanced expert system ACD/Structure Elucidator, which is capable of determining the structure and stereochemistry of large molecules, in particular, those typical in the chemistry of natural compounds, is described as an example.
    Journal of Analytical Chemistry 01/2008; 63(1):13-20. · 0.62 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The structure of the complex of the antibacterial drug trimethoprim with its target, the enzyme dihydrofolate reductase (DHFR) of Lactobacillus casei, was studied using multidimensional NMR spectroscopy. Aseries of 33 high-resolution structures of this complex in solution was calculated using the measured experimental parameters of the nuclear Overhauser effect, spin-spin coupling constants, and residual dipolar coupling constants. The key interactions leading to stable binding of the drug with the enzyme were determined. The resulting structural data were compared with structures of the ternary complex of trimethoprim and the coenzyme NADPH with bacterial (L. casei) and human DHFR that were calculated previously. The most probable reasons for cooperative interaction of trimethoprim and NADPH that determine the highly selective binding of the drug to the bacterial enzyme, in particular, the protein conformation change on going from the binary to the ternary complex of DHFR, were discussed.
    Pharmaceutical Chemistry Journal 01/2007; 41(7):350-353. · 0.32 Impact Factor